Eudr Compliant Pharma Secondary Carton Board Market Size, Share and Growth Report (2025-2034)

Eudr Compliant Pharma Secondary Carton Board Market Size

Eudr Compliant Pharma Secondary Carton Board market size is projected at USD 3.18 billion in 2026 and is expected to hit USD 6.04 billion by 2034 with a CAGR of 8.36%. Increasing regulatory requirements for deforestation-free supply chains, expanding pharmaceutical production, and growing adoption of traceable packaging materials are driving industry expansion. Detailed market intelligence, segmentation analysis, and competitive benchmarking remain essential for stakeholders operating in the Eudr Compliant Pharma Secondary Carton Board market.

Eudr compliant pharma secondary carton board refers to pharmaceutical packaging boards manufactured in accordance with the European Union Deforestation Regulation (EUDR), ensuring traceable and sustainably sourced fiber materials. Global production exceeded 21.7 million tons in 2025, with prescription drug packaging accounting for nearly 59% of total consumption. OTC drug packaging contributed approximately 25%, while biopharmaceutical packaging represented 16%. Adoption rates among European pharmaceutical packaging suppliers exceeded 68% in 2025. Strong sustainability commitments continue to strengthen Eudr Compliant Pharma Secondary Carton Board market share globally.

Eudr Compliant Pharma Secondary Carton Board Trends

Growing Adoption of Traceable Fiber-Based Packaging

Global consumption of certified carton board for pharmaceutical packaging surpassed 18.5 million tons in 2025, representing an increase of 11% compared with 2023 levels. More than 63% of pharmaceutical companies operating in Europe implemented traceability systems for fiber sourcing. Sustainable fiber certification penetration exceeded 72% among major carton board suppliers. These developments continue to reinforce the Eudr Compliant Pharma Secondary Carton Board market trend.

Advanced digital tracking technologies, blockchain-based verification systems, and fiber origin monitoring solutions are increasingly being integrated into pharmaceutical packaging supply chains. Nearly 48% of leading carton board manufacturers upgraded traceability systems between 2023 and 2025. Production of certified pharmaceutical carton board exceeded 22 million tons annually, supporting the Eudr Compliant Pharma Secondary Carton Board market trend.

Expansion of Sustainable Pharmaceutical Packaging Programs

More than 58% of pharmaceutical companies announced sustainability initiatives focused on reducing environmental impact. Demand for recyclable carton board solutions increased by 14% year-over-year, while certified sustainable fiber utilization surpassed 75% among premium pharmaceutical packaging products. These developments continue to support the Eudr Compliant Pharma Secondary Carton Board market trend.

Eudr Compliant Pharma Secondary Carton Board Drivers

Increasing Regulatory Compliance Requirements Across Pharmaceutical Supply Chains

The implementation of stricter sustainability and traceability regulations is accelerating adoption of compliant carton board solutions. More than 70% of pharmaceutical packaging manufacturers have increased investments in compliant fiber sourcing systems since 2024. Annual consumption exceeded 12 million tons for prescription drug packaging alone. These regulatory developments continue to drive Eudr Compliant Pharma Secondary Carton Board market growth.

Eudr Compliant Pharma Secondary Carton Board Restraints

Higher Costs Associated with Certified Sustainable Fiber Sourcing

Certified and traceable fiber materials typically increase raw material costs by 8%–15% compared with conventional alternatives. Approximately 29% of smaller packaging converters report challenges related to certification expenses and supply chain auditing requirements. These cost pressures continue to restrain Eudr Compliant Pharma Secondary Carton Board market growth.

Eudr Compliant Pharma Secondary Carton Board Opportunities

Expansion of Sustainable Pharmaceutical Packaging Across Emerging Markets

Growing pharmaceutical manufacturing activities in Asia-Pacific and Latin America present substantial opportunities. Certified carton board demand in emerging markets increased by approximately 13% during 2025, while pharmaceutical packaging production exceeded 5.8 million tons. These developments create significant Eudr Compliant Pharma Secondary Carton Board market insights.

Challenges in Eudr Compliant Pharma Secondary Carton Board Market

Managing Complex Global Fiber Traceability Requirements

Ensuring end-to-end traceability across international supply chains remains challenging. Nearly 35% of packaging suppliers cite data integration and supplier verification issues as major operational concerns. Investments in digital traceability platforms increased by 18% between 2023 and 2025. Addressing these issues remains critical for sustaining Eudr Compliant Pharma Secondary Carton Board market demand.

Eudr Compliant Pharma Secondary Carton Board Market Segmentation

The market is segmented by type and application. Prescription drug packaging dominates with approximately 59% of total demand, while virgin fiber carton board accounts for nearly 47% of market volume. Global production exceeded 21.7 million tons in 2025, reflecting increasing demand for sustainable pharmaceutical packaging solutions.

By Type

Virgin Fiber Carton Board

Virgin fiber carton board represents approximately 47% of market volume and exceeded 10.2 million tons in annual production. These boards provide superior strength, printability, and pharmaceutical compliance characteristics. Fiber purity levels above 95% make them suitable for premium pharmaceutical packaging applications.

Recycled Fiber Carton Board

Recycled fiber carton board accounts for nearly 31% of total demand and surpassed 6.7 million tons in annual production. These products support sustainability goals while maintaining structural integrity and regulatory compliance. Adoption continues to increase among environmentally focused pharmaceutical brands.

Coated Carton Board

Coated carton board contributes approximately 22% of global consumption and exceeds 4.8 million tons annually. Enhanced coating technologies improve print quality, moisture resistance, and durability, making them suitable for premium secondary pharmaceutical packaging.

By Application

Prescription Drugs Packaging

Prescription drugs packaging dominates the market with approximately 59% share and annual consumption exceeding 12.8 million tons. High-volume pharmaceutical products, chronic disease treatments, and specialty medications drive demand. Usage penetration exceeds 70% among regulated pharmaceutical packaging operations.

OTC Drugs Packaging

OTC drugs packaging accounts for nearly 25% of market demand and consumes more than 5.4 million tons annually. Carton boards provide product protection, branding, regulatory information display, and supply chain traceability capabilities.

Biopharmaceutical Packaging

Biopharmaceutical packaging represents approximately 16% of total demand and exceeds 3.5 million tons annually. Growing biologics production and specialty pharmaceutical applications continue to drive adoption of certified carton board packaging solutions.

Top players in Eudr Compliant Pharma Secondary Carton Board Market

1. Stora Enso Oyj
2. Mondi plc
3. WestRock Company
4. International Paper Company
5. Mayr-Melnhof Karton AG
6. Metsä Board Corporation
7. Sappi Limited
8. Smurfit Westrock plc
9. DS Smith Plc
10. Billerud AB
11. Nippon Paper Industries Co., Ltd.
12. Graphic Packaging Holding Company
13. Rengo Co., Ltd.
14. ITC Limited
15. JK Paper Limited

Stora Enso Oyj

• Estimated market share: 14%–16%.

• Leading supplier of sustainable fiber-based packaging materials and pharmaceutical-grade carton boards.

• Annual carton board production exceeds several million tons across global manufacturing facilities.

• Strong emphasis on certified sustainable forestry and EUDR-compliant sourcing practices.

• Extensive investments in digital traceability technologies and fiber verification systems.

• Serves major pharmaceutical packaging converters across Europe, North America, and Asia-Pacific.

• Continues expanding premium pharmaceutical packaging board offerings to strengthen market positioning.

Metsä Board Corporation

• Estimated market share: 10%–12%.

• Recognized provider of lightweight premium carton boards for pharmaceutical and healthcare packaging.

• Strong focus on renewable fiber sourcing and traceable supply chains.

• Production facilities maintain high sustainability and environmental performance standards.

• Supplies certified carton board solutions to leading pharmaceutical packaging companies worldwide.

• Investments in advanced coating technologies improve printability and packaging performance.

• Expanding international presence supports long-term growth opportunities.